-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Telomir Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to 2024.
- Telomir Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$2.84M, a 69.6% increase year-over-year.
- Telomir Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$16.5M, a 26.5% decline year-over-year.
- Telomir Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$16.5M, a 26.5% decline from 2023.
- Telomir Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$13.1M, a 1430% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)